Cosmetic cross-reference

Potassium Bicarbonate

CAS 298-14-6

Potassium Bicarbonate (CAS 298-14-6) is a Phase 2 pharmaceutical compound with 0 bioactivity targets and 187 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

187

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Potassium Bicarbonate

CAS Number

298-14-6

UNII

HM5Z15LEBN

InChIKey

TYJJADVDDVDEDZ-UHFFFAOYSA-M

ChEMBL ID

CHEMBL2106975

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 2

Mid-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL2106975 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE DrugCentral 7 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PT	Drug AE	LLR	MedDRA
Burkholderia test positive	9	48.991	10069960
Disease progression	26	35.267	10061818
Cholelithiasis	15	31.446	10008629
Acute kidney injury	35	31.046	10069339
Neutropenic sepsis	12	30.527	10049151
Hypomagnesaemia	13	28.47	10021027
Rash pruritic	15	27.302	10037884

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
POTASSIUM BICARBONATE	34296	SU	MTHSPL
Potassium Bicarbonate	34296	SU	MTHSPL
potassium bicarbonate	34296	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Potassium Bicarbonate used for in pharmaceutical contexts?

Potassium Bicarbonate (CAS 298-14-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Potassium Bicarbonate?

Potassium Bicarbonate has 187 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Burkholderia test positive, Disease progression, Cholelithiasis, Acute kidney injury, Neutropenic sepsis. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Potassium Bicarbonate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Potassium Bicarbonate with EU status "permitted".

What clinical phase is Potassium Bicarbonate in?

Potassium Bicarbonate is rendered with ChEMBL max phase 2.